Northwell Health’s Multidisciplinary Management of Immune Mediated Inflammatory Diseases

Saturday, December 13, 2025
8:00 am – 4:15 pm (EST)

Register Now

Meet The Faculty
Click to view Faculty

Location:
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
500 Hofstra Boulevard, Hempstead, NY 11549
Map & Driving Directions

8:00am. Registration, Breakfast, Exhibitions

8:25am. Welcome, Program Chairs

8:30am. Risk Mitigation Strategies with Biologics and Immunomdulators

• Infectious screening and vaccination (Bruce Farber)
• Latent TB reactivation, Pneumocystis pneumonia, and Hepatitis B reactivation risk and prophylaxis, Herpes zoster risk and prophylaxis (Bruce Farber)
• Cardiovascular & venous thromboembolism risk and prophylaxis (TBD)
• Moderated multidisciplinary management discussion with Q&A

9:20am. Autoinflammatory Diseases

• Updates in Management: Hidradenitis suppurativa (Amit Garg)
• Updates in Management: Pyoderma gangrenosum (Sheila Shaigany)
• Moderated multidisciplinary management discussion with Q&A

10:00am. Break, meet with sponsors

10:20am Psoriatic and Associated Diseases

• Updates in Management: Psoriasis (Sergey Rekhtman)
• Updates in Management: Psoriatic arthritis (Julie Schwartzman-Morris)
• Updates in Management: Crohn’s disease and Ulcerative Colitis (Keith Sultan)
• Updates in Management: IBD-associated arthritis and Reactive arthritis (Julie Schwartzman-Morris)
• Moderated multidisciplinary management discussion with Q&A

12:00pm. Lunch & Exhibit Hall

1:00pm. Autoimmune Diseases

• Updates in Management: Small Vessel and Medium Vessel Vasculitis (Sergey Rekhtman, Purva Sharma, Galina Marder)
• Updates in Management: Lupus (Richard Furie)
• Updates in Management: Dermatomyositis (Galina Marder)
• Moderated multidisciplinary management discussion with Q&A

2:45pm. Break, meet with sponsors

3:05pm. Drug-induced Inflammatory Disorders

• Updates in Management: Paradoxical psoriasis and eczema in biologic-treated patients (Sheila Shaigany, Ben Sahn)
• Updates in Management: Immune-related adverse effects (irAEs) from checkpoint inhibitors (Alex Barbaro, Sheila Shaigany, Kenar Jhaveri, Keith Sultan)
• Moderated multidisciplinary management discussion with Q&A

4:20 pm: Closing remarks, Program Chairs